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Background: Inflammation or scar in patients with cardiac sarcoidosis may be associated with perturbations in myocardial blood flow reserve 
(MFR). We examined MFR in 12 patients with cardiac sarcoidosis who underwent stress rest PET myocardial perfusion imaging (PET-MPI).
Method: We performed a retrospective analysis of 12 consecutive patients with cardiac sarcoidosis who underwent gated Rb-82 PET-MPI at rest 
and with vasodilator (0.4mg regadenoson) stress at the Cleveland Clinic between 2010-2013. Patients were free of significant coronary artery 
disease by invasive angiography. FDG PET was performed to identify myocardial segments with active inflammation or scar. MFR were quantified 
using commercially available software (4DM) and expressed per patient, perfusion territory and wall segment in a 17 segment model. MFR<2 was 
considered abnormal.
result: Of 12 patients, 2 had overall abnormal MFR (16%), 4 patients (33%) had abnormal MFR in at least one perfusion territory and 10 patients 
(83%) had at least one wall segment with MFR<2. These 10 patients had abnormal FDG uptake suggestive of scar or active inflammation. Among the 
2 patients with normal MFR in all 17 segments, there were no abnormalities in FDG uptake.
conclusion: Cardiac sarcoidosis may be associated with perturbations in regional and segmental MFR even when overall MFR is normal. 
Segmental and regional MFR may be a more sensitive marker of perfusion abnormalities associated with cardiac sarcoidosis than global MFR.
 
